Concepedia

Publication | Open Access

Comparison of a soluble co-formulation of insulin degludec/insulin aspart vs biphasic insulin aspart 30 in type 2 diabetes: a randomised trial

62

Citations

22

References

2012

Year

Abstract

IDegAsp provided comparable overall glycaemic control to BIAsp 30 with a significantly lower rate of hypoglycaemia.

References

YearCitations

Page 1